PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer
Public ClinicalTrials.gov record NCT04404361. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-blind, Placebo-controlled, Multicenter Study of Pacritinib Plus Standard of Care Versus Placebo and Standard of Care in Hospitalized Patients With Severe COVID-19 With or Without Cancer
Study identification
- NCT ID
- NCT04404361
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- CTI BioPharma
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2020
- Primary completion
- Sep 20, 2021
- Completion
- Sep 20, 2021
- Last update posted
- Jun 4, 2024
2020 – 2021
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Jude Hospital Yorba Linda dba St. Joseph Heritage Healthcare | Orange | California | 92868 | — |
| Ascension St. Vincent's Riverside Hospital | Jacksonville | Florida | 32204 | — |
| Grady Memorial Hospital | Atlanta | Georgia | 30303 | — |
| St. Vincent Medical Group, Inc | Indianapolis | Indiana | 46220 | — |
| St. Agnes Healthcare | Baltimore | Maryland | 21229 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Ascension St. John Hospital | Detroit | Michigan | 48236 | — |
| Ascension Providence Hospital - Novi Campus | Novi | Michigan | 48374 | — |
| Providence Cancer Institute | Southfield | Michigan | 48075 | — |
| Atlantic Melanoma Center | Morristown | New Jersey | 07960 | — |
| Overlook Medical Center | Morristown | New Jersey | 07960 | — |
| Chilton Medical Center | Pompton Plains | New Jersey | 07444 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital | Cincinnati | Ohio | 45219 | — |
| St. John Medical Center | Tulsa | Oklahoma | 74104 | — |
| Albert Einstein Medical Center | Philadelphia | Pennsylvania | 19141 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| The Miriam Hospital | Providence | Rhode Island | 02903 | — |
| Ascension St. Francis Hospital | Milwaukee | Wisconsin | 53215 | — |
| Ascension All Saints | Racine | Wisconsin | 53405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04404361, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2024 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04404361 live on ClinicalTrials.gov.